Crossmark

Mercury-associated diagnoses among children diagnosed with pervasive development disorders

Crossref DOI link: https://doi.org/10.1007/s11011-018-0211-9

Published Online: 2018-03-06

Published Print: 2018-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Geier, David A.

Kern, Janet K. https://orcid.org/0000-0003-0556-0384
Sykes, Lisa K.

Geier, Mark R.
Funding

Funding for this research was provided by:

Institute of Chronic Illnesses

CoMeD, Inc.
License Information

Text and Data Mining valid from 2018-03-06
More Information

Article History

Received: 22 September 2017

Accepted: 25 February 2018

First Online: 6 March 2018

Compliance with ethical standards

:

: There are no competing financial interests. The authors were previously involved in vaccine/biologic litigation. Dr. Mark Geier, Mr. David Geier, and Dr. Janet Kern have been involved as consultants and expert witnesses for petitioners in the no-fault National Vaccine Injury Compensation Program (NVICP) and have also been consultants and expert witness for plaintiffs in civil litigation. They are not involved in any current cases, have not been involved in any cases for several years, and have no plans to be involved in any future cases. Dr. Mark Geier and David Geier are directors of the Institute of Chronic Illnesses, Inc., and CoMeD, Inc. Lisa Sykes is the President of CoMeD, Inc. No other authors have a management or directorship position at the Institute of Chronic Illnesses, Inc., or CoMeD, Inc.